Guerbet SA (GBT)-Financial and Strategic SWOT Analysis Review
- Table Of Content
- Licence Rights
- Section Purchase
- Products and Companies
Guerbet SA (GBT)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
Business description-A detailed description of the company's operations and business divisions.
Corporate strategy-Analyst's summarization of the company's business strategy.
SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.
Company history-Progression of key events associated with the company.
Major products and services-A list of major products, services and brands of the company.
Key competitors-A list of key competitors to the company.
Key employees-A list of the key executives of the company.
Executive biographies-A brief summary of the executives' employment history.
Key operational heads-A list of personnel heading key departments/functions.
Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.
Key manufacturing facilities-A list of key manufacturing facilities of the company.
Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Guerbet SA (Guerbet) is a specialty pharmaceutical company which manufactures and markets medical imaging contrast agents destined for diagnostic purposes. The company provides a wide range of contrast agents for X-ray examinations and Magnetic Resonance Imaging (MRI). Guerbet also provides interventional radiology and theranostics (IRT) and medical devices. The company through its subsidiary Simafex conducts custom synthesis and toll manufacture of advanced intermediates and active ingredients for the pharmaceutical industry. Guerbet's manufacturing facilities are ISO 9001 certified. The company and its subsidiaries have operations in various countries across Europe, Asia and Americas. It also operates a network of distributors across the world. Guerbet is headquartered in Villepinte, France.
Guerbet SA Key Recent Developments
Jul 10,2017: Guerbet Announces Plans to Streamline Its Contrast Media Portfolio
Apr 27,2017: GUERBET: 1st quarter 2017 revenue
Mar 29,2017: GUERBET : 2016 annual results
Feb 27,2017: Guerbet Will Present Its Innovative Solutions for Medical Imaging at ECR 2017
Feb 15,2017: GUERBET : 2016 Annual Revenue: EUR788.8 million, +7.1% growth in Q4
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
Table Of Content
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Section 1-About the Company 5
Guerbet SA-Key Facts 5
Guerbet SA-Key Employees 6
Guerbet SA-Key Employee Biographies 7
Guerbet SA-Major Products and Services 8
Guerbet SA-History 9
Guerbet SA-Company Statement 11
Guerbet SA-Locations And Subsidiaries 12
Head Office 12
Other Locations & Subsidiaries 12
Section 2-Company Analysis 15
Guerbet SA-Business Description 15
Guerbet SA-Corporate Strategy 16
Guerbet SA-SWOT Analysis 17
SWOT Analysis-Overview 17
Guerbet SA-Strengths 17
Guerbet SA-Weaknesses 18
Guerbet SA-Opportunities 19
Guerbet SA-Threats 20
Guerbet SA-Key Competitors 21
Section 3-Company Financial Ratios 22
Financial Ratios-Capital Market Ratios 22
Financial Ratios-Annual Ratios 23
Performance Chart 26
Financial Performance 26
Financial Ratios-Interim Ratios 27
Financial Ratios-Ratio Charts 28
Guerbet SA, Recent Deals Summary 29
Section 4-Company's Recent Developments 30
Jul 10, 2017: Guerbet Announces Plans to Streamline Its Contrast Media Portfolio 30
Apr 27, 2017: GUERBET: 1st quarter 2017 revenue 31
Mar 29, 2017: GUERBET : 2016 annual results 32
Feb 27, 2017: Guerbet Will Present Its Innovative Solutions for Medical Imaging at ECR 2017 33
Feb 15, 2017: GUERBET : 2016 Annual Revenue: EUR788.8 million, +7.1% growth in Q4 34
Sep 28, 2016: Guerbet: 2016 half-year results on track 35
Jul 28, 2016: Guerbet: Revenue at June 30, 2016: EUR376.7 million, up 65.7% 36
Apr 27, 2016: Guerbet Announces 1 st quarter 2016 revenue 37
Apr 14, 2016: Guerbet: Record earnings in 2015 38
Feb 10, 2016: 2015 Annual Revenue: EUR449.4 million: +10.0% at constant exchange rates 40
Section 5-Appendix 41
Ratio Definitions 41
About GlobalData 45
Contact Us 45
List Of Figure
List of Figures
Guerbet SA, Performance Chart (2012-2016) 26
Guerbet SA, Ratio Charts 28
List Of Table
List of Tables
Guerbet SA, Key Facts 5
Guerbet SA, Key Employees 6
Guerbet SA, Key Employee Biographies 7
Guerbet SA, Major Products and Services 8
Guerbet SA, History 9
Guerbet SA, Other Locations 12
Guerbet SA, Subsidiaries 12
Guerbet SA, Key Competitors 21
Guerbet SA, Ratios based on current share price 22
Guerbet SA, Annual Ratios 23
Guerbet SA, Annual Ratios (Cont...1) 24
Guerbet SA, Annual Ratios (Cont...2) 25
Guerbet SA, Interim Ratios 27
Guerbet SA, Recent Deals Summary 29
Currency Codes 41
Capital Market Ratios 41
Equity Ratios 42
Profitability Ratios 42
Cost Ratios 43
Liquidity Ratios 43
Leverage Ratios 44
Efficiency Ratios 44
Single User License:
Report can be used by individual purchaser only
Report can be shared by unlimited users within one corporate location, e.g. a regional office
Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company
Products and Companies
Guerbet SA, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts